Allison Bratzel
Stock Analyst at Piper Sandler
(4.94)
# 144
Out of 4,512 analysts
240
Total ratings
66.7%
Success rate
43.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Allison Bratzel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABVX ABIVAX Société Anonyme | Rated: Buy | $165 → $175 | $134.91 | +29.72% | 13 | Jul 9, 2026 | |
| MGTX MeiraGTx Holdings | Maintained: Buy | $30 | $12.44 | +141.16% | 6 | Jul 8, 2026 | |
| HUMA Humacyte | Maintained: Hold | $1 | $0.7072 | +41.40% | 9 | Jun 18, 2026 | |
| INCY Incyte | Maintained: Buy | $110 | $114.88 | -4.25% | 12 | Jun 9, 2026 | |
| TVTX Travere Therapeutics | Maintained: Buy | $49 | $57.06 | -14.13% | 20 | Jun 3, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintained: Buy | $84 → $82 | $58.64 | +39.84% | 6 | May 21, 2026 | |
| RIGL Rigel Pharmaceuticals | Maintained: Hold | $40 | $41.17 | -2.84% | 9 | May 13, 2026 | |
| ARGX argenx SE | Maintained: Buy | $1,075 | $859.43 | +25.08% | 33 | May 11, 2026 | |
| ALXO ALX Oncology Holdings | Maintained: Buy | $4 | $2.00 | +100.00% | 6 | May 11, 2026 | |
| CDXS Codexis | Maintained: Buy | $9 | $2.13 | +322.54% | 11 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $26 → $4 | $1.90 | +111.08% | 4 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $68 | $32.03 | +112.30% | 6 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $52 | $38.51 | +35.03% | 8 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $5.16 | +210.08% | 8 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $54.93 | +82.05% | 13 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $1.40 | +185.71% | 17 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $5.21 | +130.33% | 5 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 → $4 | $9.87 | -59.47% | 8 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $14.94 | +100.80% | 6 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 → $56 | $32.88 | +70.32% | 5 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 → $58 | $53.78 | +7.85% | 13 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 → $0.5 | $0.005 | +9,900.00% | 5 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $17 | $6.74 | +152.23% | 5 | Jul 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $34.91 | n/a | 6 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $8 → $20 | $9.63 | n/a | 6 | Mar 14, 2024 |
ABIVAX Société Anonyme
Jul 9, 2026
Rated: Buy
Price Target: $165 → $175
Current: $134.91
Upside: +29.72%
MeiraGTx Holdings
Jul 8, 2026
Maintained: Buy
Price Target: $30
Current: $12.44
Upside: +141.16%
Humacyte
Jun 18, 2026
Maintained: Hold
Price Target: $1
Current: $0.7072
Upside: +41.40%
Incyte
Jun 9, 2026
Maintained: Buy
Price Target: $110
Current: $114.88
Upside: -4.25%
Travere Therapeutics
Jun 3, 2026
Maintained: Buy
Price Target: $49
Current: $57.06
Upside: -14.13%
BioMarin Pharmaceutical
May 21, 2026
Maintained: Buy
Price Target: $84 → $82
Current: $58.64
Upside: +39.84%
Rigel Pharmaceuticals
May 13, 2026
Maintained: Hold
Price Target: $40
Current: $41.17
Upside: -2.84%
argenx SE
May 11, 2026
Maintained: Buy
Price Target: $1,075
Current: $859.43
Upside: +25.08%
ALX Oncology Holdings
May 11, 2026
Maintained: Buy
Price Target: $4
Current: $2.00
Upside: +100.00%
Codexis
May 8, 2026
Maintained: Buy
Price Target: $9
Current: $2.13
Upside: +322.54%
May 8, 2026
Downgraded: Hold
Price Target: $26 → $4
Current: $1.90
Upside: +111.08%
May 7, 2026
Maintained: Buy
Price Target: $68
Current: $32.03
Upside: +112.30%
May 7, 2026
Maintained: Buy
Price Target: $52
Current: $38.51
Upside: +35.03%
May 1, 2026
Maintained: Buy
Price Target: $16
Current: $5.16
Upside: +210.08%
Apr 24, 2026
Maintained: Buy
Price Target: $100
Current: $54.93
Upside: +82.05%
Apr 24, 2026
Maintained: Buy
Price Target: $4
Current: $1.40
Upside: +185.71%
Apr 21, 2026
Maintained: Buy
Price Target: $12
Current: $5.21
Upside: +130.33%
Apr 10, 2026
Downgraded: Hold
Price Target: $14 → $4
Current: $9.87
Upside: -59.47%
Mar 24, 2026
Maintained: Buy
Price Target: $30
Current: $14.94
Upside: +100.80%
Mar 20, 2026
Maintained: Buy
Price Target: $42 → $56
Current: $32.88
Upside: +70.32%
Mar 4, 2026
Maintained: Buy
Price Target: $51 → $58
Current: $53.78
Upside: +7.85%
Jan 23, 2026
Downgraded: Hold
Price Target: $3 → $0.5
Current: $0.005
Upside: +9,900.00%
Jul 28, 2025
Maintained: Buy
Price Target: $20 → $17
Current: $6.74
Upside: +152.23%
Jul 18, 2024
Maintained: Buy
Price Target: $22
Current: $34.91
Upside: n/a
Mar 14, 2024
Upgraded: Buy
Price Target: $8 → $20
Current: $9.63
Upside: n/a